Psychotropic medications in oncology and in AIDS patients.
This chapter has reviewed the prevalence of cancer and of psychiatric syndromes in the cancer setting. Guidelines have been given for the evaluation and treatment of specific psychiatric syndromes, as well as several special problems found in the cancer setting. In general, the major principle of using psychiatric medications in the patient with cancer or advanced AIDS is to use them to improve comfort, and not to withhold them when they may be of benefit.
Bluestine
S
S
Memorial Sloan-Kettering Cancer Center, New York, N.Y.
Lesko
L
L
D015526:AIDS Dementia Complex / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D015897:Comorbidity; D004347:Drug Interactions; D006801:Humans; D008657:Metabolic Clearance Rate / Q000502:physiology; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D019965:Neurocognitive Disorders / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D010166:Palliative Care; D010348:Patient Care Team; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012803:Sick Role
D011619:Psychotropic Drugs